Bold Eagle Acquisition Corp.

Historical 13F Holders

Symbol
BEAG
CUSIP
G2003N105
All holders as of
Q2 2026
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G2003N105 since 12/18/2024, newest first.

Filer % of Class Filed
Harraden Circle Investments, LLC 13G/A Amendment 2
9.1% 8/14/2026
Event 6/30/2026
Goldman Sachs Group Inc 13G/A Amendment 1
3.5% 8/13/2026
Event 6/30/2026
Goldman Sachs Group Inc 13G
5.0% 5/12/2026
Event 3/31/2026
Harraden Circle Investments, LLC 13G/A Amendment 1
9.8% 2/13/2026
Event 12/31/2025
Centiva Capital, LP 13G/A Amendment 1
0% 2/12/2026
Event 12/31/2025
Meteora Capital, LLC 13G 5.2% 11/14/2025
Event 9/30/2025
Centiva Capital, LP 13G
6.0% 11/14/2025
Event 9/30/2025
Lighthouse Investment Partners, LLC 13G/A Amendment 1
0.6% 11/14/2025
Event 9/30/2025
Harraden Circle Investments, LLC 13G
6.0% 10/31/2025
Event 10/24/2025
Lighthouse Investment Partners, LLC 13G
5.4% 8/14/2025
Event 6/30/2025
Harraden Circle Investments, LLC 13G/A Amendment 1
1.5% 8/14/2025
Event 6/30/2025
Millennium Management LLC 13G/A Amendment 2
2.1% 7/16/2025
Event 6/30/2025
AQR Capital Management, LLC 13G/A Amendment 1
7.9% 5/14/2025
Event 3/31/2025
Healthcare of Ontario Pension Plan Trust Fund 13G/A Amendment 1 0.8% 5/14/2025
Event 3/31/2025
Bank of Montreal /Can/ 13G/A Amendment 1
1.1% 5/8/2025
Event 4/30/2025
Bank of Montreal /Can/ 13G
6.2% 5/8/2025
Event 3/31/2025
Harraden Circle Investments, LLC 13G
6.4% 5/5/2025
Event 4/29/2025
Millennium Management LLC 13G/A Amendment 1
6.2% 4/8/2025
Event 4/2/2025
Barclays PLC 13G/A Amendment 1 7.3% 3/21/2025
Event 12/31/2024
Healthcare of Ontario Pension Plan Trust Fund 13G 8.4% 2/14/2025
Event 12/31/2024
Barclays PLC 13G 7.3% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 57 23.1 M $247 M
2026 Q1 54 23.1 M $243 M
2025 Q4 51 22.4 M $234 M
2025 Q3 52 22.9 M $238 M
2025 Q2 59 24.5 M $257 M
2025 Q1 40 19.1 M $178 M
2024 Q4 28 12.4 M $122 M